...
首页> 外文期刊>Clinical nephrology >Effects of early hemofiltration on organ function and intra-abdominal pressure in severe acute pancreatitis patients with abdominal compartment syndrome
【24h】

Effects of early hemofiltration on organ function and intra-abdominal pressure in severe acute pancreatitis patients with abdominal compartment syndrome

机译:早期血液过滤对腹腔室综合征严重急性胰腺炎患者器官功能和腹部压力的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To study the effects of early continuous veno-venous hemofiltration (CVVH) on organ function and intraabdominal pressure (IAP) in severe acute pancreatitis (SAP) patients with abdominal compartment syndrome (ACS). Materials and methods: 48 SAP patients with ACS were included in this study. Among them, 37 patients, receiving both conventional treatment and hemofiltration therapy in the ICU, were regarded as the treatment group, and the rest, receiving only conventional treatment, were regarded as the control group. Symptoms, signs, and adverse reactions of both groups were observed and recorded during treatments. Serum and urine amylase, liver and kidney function, C-reactive protein, and intra-abdominal pressure of the patients were detected before and on days 1, 2, 3, 4, 5, and 6 after treatment. Results: 1. Symptoms and signs in the treatment group disappeared quickly, and their hospitalization time was significantly shorter than those of control group (p < 0.05). 2. After treatment, on days 1, 2, 3, 4, 5, and 6, patients' senun and urine amylase levels, C-reactive protein, and intraabdominal pressure were significantly lower, and liver and kidney function was significantly better than those of the control group (p < 0.05). Conclusion: Early hemofiltration in SAP with ACS can effectively reduce intra-abdominal pressure, improve symptoms, accelerate liver and renal function recovery, avoid multiple organ failure and decrease mortality rate.
机译:目的:研究早期连续静脉血液过滤(CVVH)对腹腔室综合征(ACS)严重急性胰腺炎(SAP)患者器官功能和腹腔内压(IAP)的影响。材料和方法:本研究纳入48例ACS患者。其中,37名患者,接受ICU的常规治疗和血液过滤治疗,被视为治疗组,其余的接受常规治疗被视为对照组。在治疗过程中观察和记录了两组的症状,迹象和不良反应。在治疗后,检测血清和肾功能,肝肾功能,肝肾功能,C反应蛋白和患者的腹部压力。结果:1。治疗组的症状和迹象迅速消失,其住院时间明显短于对照组(P <0.05)。 2.在治疗后,在第1,2,3,4,5和6天,患者的患者的脑内和尿淀粉酶水平,C-反应蛋白和腹腔压力显着降低,肝肾功能明显优于那些对照组(P <0.05)。结论:随着ACS的SAP早期血液过滤可以有效降低腹内压力,改善症状,加速肝脏和肾功能恢复,避免多器官衰竭并降低死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号